The frequency of the 4allele of apolipoprotein E (apoE) is increased in late-onset and sporadic forms of Alzheimer's disease (AD). ApoE also binds to ß-amyloid (Aß) and both proteins are found in AD plaques. To further investigate the potential interaction of apoE and Aß in the pathogenesis of AD, we have determined the binding, internalization, and degradation of human apoE isoforms in the presence and absence of Aß peptides to rat primary hippocampal neurons. We demonstrate that the lipophilic Aß peptides, in particular Aß 142, Aß140, and Aß2535, increase significantly apoE-liposome binding to hippocampal neurons. For each Aß peptide, the increase was significantly greater for the apoE4 isoform than for the apoE3 isoform. The most effective of the Aß peptides to increase apoE binding, Aß2535, was further shown to increase significantly the internalization of both apoE3-and apoE4-liposomes, without affecting apoE degradation. Conversely, Aß140 uptake by hippocampal neurons was shown to be increased in the presence of apoE-liposomes, more so in the presence of the apoE4 than the apoE3 isoform. These results provide evidence that Aß peptides interact directly with apoE lipoproteins, which may then be transported together into neuronal cells through apoE receptors. Key Words: Alzheimer's disease-Apolipoprotein E-ß-Amyloid peptide-HippocampaI neurons-Apolipoprotein E binding-Liposomes-Apolipoprotein E3 and E4 isoforms.
Apolipoprotein E (apoE) is a lipid-binding, 34-kDa, 299-amino acid protein involved in cholesterol and phospholipid transport and metabolism. ApoE mediates the uptake of lipid complexes by acting as a ligand for several receptors including the low-density lipoprotein (LDL) receptor (Mahley, 1988) , the LDL receptorrelated protein (LRP) (Beisiegel et al., 1989) , the verylow-density lipoprotein (VLDL) receptor (Takahashi et al., 1992) , and also possibly through the newly discovered apoE receptor 2 (apoER2) . The LDL receptor pathway consists of cell surface binding of apoE-containing lipoproteins followed by internalization and degradation of the apoE complex by a lysosomal pathway (Goldstein et al., 1983) . The major sites of apoE synthesis are the liver, brain, spleen, lung, adrenal, ovary, kidney, and muscle (Elshourbagy et al., 1985) . In the brain, apoE mRNA is present mostly in astrocytes (Poirier et al., 1991) , and apoE is found in the CSF as a component of lipoproteins and lipid complexes (Boyles et al., 1985; Pitas et al., 1987a,b) . Several apoE receptors have been identified in the brain, including the LDL receptor (Pitas et al., 1987b; Swanson et al., 1988) , LRP (Wolf et al., 1992; Rebeck et al., 1993) , VLDL receptor (Gafvels et al., 1994; Christie et al., 1996) , and apoER2 .
The structural gene for apoE is polymorphic, leading to three major isoforms, designated apoE2, apoE3, and apoE4, which are derived from the 2, 3, and 4 alleles, respectively (Davignon et al., 1988) . Among the major apoE isoforms, the frequency of the apoE 4 allele is increased significantly in sporadic and lateonset familial cases of Alzheimer's disease (AD) compared with the general population (Corder et al., 1993; Poirier et al., 1993; Rebeck et al., 1993; . The physiological role of apoE in the pathogenesis of AD is presently unknown; however, growing evidence points to a key role for apoE in synaptic plasticity (Poirier, 1994; Poirier et al., 1995; Arendt et al., 1997) . Another theory involves an interaction of apoE with the amyloidogenic fragments of the amyloid precursor protein (APP). Recent evidence suggests apoE and ß-amyloid (Aß) peptides form stable sodium dodecyl sulfate (SDS)-resistant complexes, indicative of strong intermolecular binding (Strittmatter et al., 1993; LaDu et al., 1994 LaDu et al., , 1995 Yang et al., 1997) . ApoE has been shown to reduce polymerization of Aß in vitro (Evans et al., 1995) as well as reduce Aß toxicity in neuronal cell cultures (Whitson et al., 1994; Puttfarcken et al., 1997) . By using autopsied AD brain tissue, apoE has also been localized to extracellular senile plaques, intracellular neurofibrillary tangles, and vascular amyloid, the neuropathological lesions characteristic of AD (Namba et al., 1991) . Strong associations have been found between the apoE4 allele and increased vascular and parenchymal Aß deposition Beffert and Poirier, 1996) . Collectively, these data have led to the hypothesis that apoE and Aß interact by some physiological mechanism that underlies the pathogenesis of AD.
In the present study, we have sought to further define the functional role of apoE and the potential interaction with Aß. We have characterized the binding, internalization, and degradation of the two most common apoE isoforms on rat primary hippocampal neurons in the presence and the absence of Aß peptides. We demonstrate that apoE-liposome binding and internalization are increased by Aß peptides in an isoform-specific manner and, conversely, that neuronal Aß uptake can be increased by apoE-liposomes. These data further establish a physiological link between apoE, Aß, and AD.
MATERIALS AND METHODS

Materials
Various Aß peptides including Aß 140, Aß14,, Aß1_25, Aß25-~~‚ and Aß40_1 were purchased from Bachem (Torrance, CA, U.S.A.). The scrambled peptide Aß2535 was a kind gift of P. Gaudreau (Notre-Dame Hospital Research Centre, Montreal, Quebec, Canada). Materials used for cell culture were obtained from GibcoBRL (Rockville, MD, U.S.A.). Bolton-Hunter reagent was purchased from Du Pont-NEN (Boston, MA, U.S.A.). Unless otherwise stated, all other chemicals were obtained from Sigma (Oakville, Ontario, Canada).
ApoE purification
Human apoE was purified from the plasma of pregenotyped apoE-homozygous individuals as previously described (Guillaume et al., 1996) . In brief, 10 ‚aM phenylmethylsulfonyl fluoride, 0.3 mM EDTA, and 3 mM sodium azide were added to all sera, which were then ultracentrifuged at 8.5 X iO~g for 30 min at 16°Cand then twice at 1.8 X l0g -h to isolate and wash the VLDL. An equal volume of isopropanol was added to a 1.5 mg/mI VLDL solution during vigorous agitation, followed by centrifugation at 10,000 g for 10 min. The isopropanol was evaporated under a jet of nitrogen, and acetone (1.2 times the volume) was added to the remaining solution, which was centrifuged at 20,000 g for 20 min. The pellet containing apoE was resuspended in NaC1 (150 mM) and the acetone extraction was repeated. Solvent-extracted apolipoproteins were delipidated by extracting twice with chloroform/methanol (2: I), each time followed by centrifugation at 20,000 g for 20 min. Delipidated proteins were dissolved in Tris-HCI buffer (10 mM; pH 7.4) containing NaC1 (150 mM), EDTA (0.3 mM), and urea (5.0 M). Solutions were then centrifuged at 10,000 g for 10 min and then dialysed against the same buffer containing no urea.
ApoE-liposome construction
ApoE-containing liposomes were prepared according to the method of Matz and Jonas (1982) with the following conditions: 100 mol of phosphatidylcholine/1 00 mol of cholate/25 mol of cholesterol/mol of apoE. The mixtures were incubated for 12 h at 4°Cand were dialysed for 48 h with four changes of Tris-HC1 (10 mM) buffer, pH 7.4, containing NaCl (150 mM) and EDTA (0.3 mM). ApoE-liposomes were isolated via centrifugation at 3 X 106 g-h at a density of 1.125 g/ml, and the isolated fraction was dialysed against a NaCl (150 mM) solution, pH 7.5, containing 0.3 mM EDTA and 3 mM sodium azide.
ApoE radioiodination
ApoE-liposomes were labeled according to the BoltonHunter procedure (Innerarity et al., 1979) . Human apoE (100-200~.tg)in 100~zlof potassium phosphate buffer (pH 7.5) was added to I mCi of dried Bolton-Hunter reagent. The reaction was left on ice for 4 h at 4°Cwith occasional gentle agitation. The labeling reaction was terminated with 200 fil of glycine (I mg/mi in potassium phosphate buffer). The radiolabeled apoE was then separated, using a preequilibrated (0.1% gelatin in phosphate buffer) Sephadex G-25 (Pharmacia) column, and the protein fractions were pooled and collected. Protein-lipid labeling ratios were monitored routinely and found to be -~95:5for protein/lipid.
Hippocampal neurons
Primary hippocampal neuronal cells were obtained from the hippocampus of embryonic (E18-19) Sprague-Dawley rats (Charles River). All procedures were performed in accordance with the Canadian ouncil on Animal Care Guidelines and the Society for Neuroscience Policy on the Use of Animals in Research. Neurons were plated at a density of 5 X l0~cells/16-mm 2 well in poly-n-lysine-coated tissue culture dishes and maintained in a serum-free supplemented growth medium (GIBCO B27). On the day after plating, the cell culture medium was replaced with fresh medium. Experiments were performed after 6 days in culture, at which time the pyramidal neurons are fully differentiated (Mattson et al., 1991) . By using these procedures, contamination by glial and other cell types is limited to <2.5% of all cells.
ApoE-liposome and Aß preincubation
Aß peptides were dissolved in 3% dimethyl sulfoxide in double-distilled H 20 at a stock concentration of 1 mg/mI. Unused aliquots were stored at -80°Cuntil further use. 1251.. labeled apoE-liposomes (see Figs. 1-3) and unlabeled apoEliposomes (see Fig. 4 ) were then preincubated with the indicated Aß peptides for 2 h at 37°C,with the preincubation concentrations proportional to the final concentrations indicated. Treated neurons were monitored routinely for toxicity by using either lactate dehydrogenase (LDH) or 3-(4,5-dimethylthiazol-2-yl)-2,5-dïphenyltetrazoliumbromide (MTT) colorimetric assay.
Binding, internalization, and degradation
Binding assays of ' 251-labeled apoE-liposomes were mea- Neurons were then washed thoroughly with ice-cold phosphate-buffered saline (PBS) buffer with 0.2% BSA and then again with PBS. Cells were then detached with 0.1 M NaOH and the amount of radioactivity determined. For 37°C studies, neurons were incubated with ligand as above for 4 h. The incubation medium was then removed and the degradation products determined from the trichloroacetic acid-soluble supernatant as previously described (Goldstein et al., 1983) . Cells were then washed on ice with PBS as above and then incubated with ice-cold 25 mM sodium suramin for 1 h on a rotary shaker. The released fraction of radioactivity was used to determine the bound fraction. Cells were then rinsed with PBS and detached with 0.1 M NaOH to determine the internalized fraction. 
Western blotting experiments
Unlabeled apoE and Aß were preincubated for 2 h at 37°C
as above. The mixture was then diluted to concentrations of I ‚ag/ml for both apoE and Aß. The cells were incubated with this mixture in DMEM for a period of 24 h. The cells were then harvested from the Petri dishes and sonicated briefly to disrupt the membranes. Samples were pelleted, aliquoted, and stored at -80°Cfor protein assay. By using the method of Laemmli (1970) , cell homogenates (25 ‚ag of total protein) were mixed with 5X reducing sample buffer, boiled for I mm, and run on Novex 12% Tris-glycine gels for apoE or 10-20% tricine gels for Aß (Helixx Technologies, Canada) for SDS-polyacrylamide gel electrophoresis. Proteins were transferred onto nitrocellulose membranes (Amersham) and probed with antibodies to apoE or Aß. For apoE detection, membranes were probed with a polyclonal goat anti-human apoE antibody (IIC; Murrieta, CA, U.S.A.) diluted 1:2,000. Aß detection was performed by using monoclonal antibody 4G8 recognizing Aß peptides 17-24 (1:500; kindly provided by M. R. Emmerling). All membranes were visualized by using Amersham' s enhanced chemiluminescence kit and exposed to Kodak XAR5 film.
Statistics
Binding parameters were determined by using GraphPad Prism 2.0 software (San Diego, CA, U.S.A.). A one-way ANOVA or Student's t test was used to test the significance of changes observed under different conditions. Quantification of autoradiographic signals was performed by using the MCID image-analysis system (St. Catharines, Ontario, Canada) equipped with one-dimensional gel-analysis software.
RESULTS
Saturation binding of apoE to hippocampal neurons
To demonstrate apoE function in the CNS, we decided to establish a model that mimics as closely as possible the conditions found in this environment. Liposome complexes of human apoE were used, primarily because it has been shown that total delipidation of apoE-containing lipoproteins abolishes the ability of apoE to bind to its receptors (Innerarity et al., 1979) . Second, apoE has been shown to be present in human CSF as high-density lipoprotein (HDL)-like particles that are comparable in size with the liposomes used here (Pitas et al., 1987b) . Furthermore, the CSF concentration of apoE in rats is similar to that found in humans,~-'450 ‚ag/dl (Chiba et al., 1991) . Binding of human apoE-liposome complexes to rat hippocampal neurons therefore provides an excellent model for investigating the function of apoE in the CNS.
Human apoE3-and apoE4-liposomes bound avidly and comparably with rat hippocampal neurons at 4°C, yielding a typical saturation profile (Fig. 1) . Nonlinear regression analysis revealed an average KD of 72.7 ±13.6 nIl~I for apoE3 and 78.5 ± 18.8 nM for apoE4.
Maximum binding was determined yielding Bmax = 921.5 ±43.0 and 1,031.0 ±62.9 ng '251-apoE/mg of total protein for apoE3-and apoE4-liposomes, respectively. Nonspecific binding was determined in the presence of an excess of 500-fold unlabeled LDL. A 100-fold excess of unlabeled human apoE3-liposomes and apoE4-liposomes was equally effective as a 500-fold excess of human LDL in displacing the binding of the labeled ligands, with 500-fold human VLDL displaying slightly less efficacy (Table 1) . Liposomes containing no native apolipoprotein were ineffective at displacing either iodinated ligand.
ApoE binding with preincubated Aß
lodinated apoE and Aß were preincubated for 2 h at 37°Cto maximize potential protein-protein interactions. The preincubation period of 2 h used here was previously shown to demonstrate maximal apoE isoform-specific differences in binding to Aß (Strittmatter et al., 1993) . The mixture was then diluted into the he concentration of liposomes was 17.5 jig of liposomes/ml of media. This is the same concentration of liposomes present in the apoE-liposomes at a concentration of 100 jig/mI. cell culture media used for the binding experiment. Binding experiments were then performed at 4°C as described in Materials and Methods. Figure 2A demonstrates that Aß 2535 was capable of increasing significantly the binding of both apoE3-and apoE4-liposomes to rat hippocampal neurons at concentrations as low as lO~M (p < 0.0001). The increase in binding was maximal at i0~M Aß2535 for both apoE3-and apoE4-liposomes. Furthermore, apoE4-liposome binding was consistently higher than apoE3-liposome binding at equal concentrations of Aß2555 (F = 21.57; df 1,108; p < 0.0001). In contrast, two control peptides, scrambled Aß2535 and Aß40_1, were ineffective at increasing apoE3-or apoE4-liposome binding to hippocampal neurons (Fig. 2B) . Figure 2C and D demonstrates the binding of apoE3-and apoE4-liposomes in the presence of increasing concentrations of Aß128, Aß140, and Aß142. Aß1_40 and Aß142 peptides displayed similar efficacy at increasing the binding of both apoE3-and apoE4-liposomes to hippocampal neurons. Both Aß140 and Aß142 increased apoE4-liposome binding significantly and comparably more than apoE3-liposome binding at equimolar concentrations (F = 17.99; df 1,108; p < 0.0001 for Aß140 F = 49.80; df 1,108; p < 0.0001 for Aß1_42). Aß1.25 peptide did not increase the binding of either apoE3-or apoE4-liposomes compared with control values (p > 0.05).
The Aß peptides used here in their aggregated forms are toxic to many cell types including neurons (Pike et al., 1993; Takadera et al., 1993) . However, apoE has also been shown to inhibit Aß fibril formation 1251-apoE3-and 125l-apoE4-liposomes (1 jig/mI) with increasing concentrations of Aß 142, Aß140, and Aß128, respectively. Scales of C and D were maintained to facilitate comparison of apoE isoforms.
U. BEFFERT ET AL.
( Evans et al., 1995) as well as decrease the toxicity induced by Aß peptides in rat hippocampal neuronal cultures (Puttfarcken et al., 1997) . We routinely verified neuronal toxicity with both MTT and LDH assays and found that conditions incubated with combinations of apoE and Aß displayed no variations from control, untreated cell cultures (data not shown).
Binding, internalization, and degradation of apoE isoforms with and without Aß 2535
Because the Aß25_35 fragment was found to be the most potent at increasing the binding of apoE to hippocampal neurons, it was considered appropriate to continue with this peptide for further analysis of internalization and degradation. It is noteworthy that the Aß25_35 peptide is also the proposed biologically active fragment of Aß (Yankner et al., 1990) . Figure 3 demonstrates the increase in 37°C binding and internalization, using a range of apoE3-and apoE4-liposome concentrations in the presence of a fixed concentration of Aß25 35 (1 ‚ag/ ml). Nonlinear regression was used to fit data points to the curves. Both apoE-liposome preparations demonstrated significant increases in binding ( Fig. 3A and B) and internalization ( Fig. 3C and D) due to the presence of Aß25_35 (p < 0.0001, in each case). At equimolar concentrations of apoE, Aß25_35 increased the amount of binding and internalization of apoE4-liposomes more than apoE3-liposomes (p < 0.0001). The amount of degradation measured was not affected by the presence of Aß2535 however, apoE3-liposome degradation was found to be significantly higher than apoE4-liposome degradation at equimolar concentrations (p < 0.0001; Fig. 3E and F) .
ApoE and Aß uptake by immunoblot
To determine if the increase in apoE binding and internalization to neurons also affected Aß levels, parallel experiments were run to determine apoE and Aß uptake by measuring immunoreactive levels of apoE and Aß. Unlabeled apoE3-and apoE4-liposomes were preincubated with Aß peptides and then incubated in the cell culture medium for 24 h at 37°C.Immunoblots for apoE ( Fig. 4A and B) yielded results similar to those for apoE3-and apoE4-liposome binding and internalization. Aß2535 was the most potent of the Aß peptides tested, at increasing the amount of apoE immunoreactivity measured from neuronal cell homogenates. Aß2535 increased significantly both apoE3 and apoE4 levels as determined by immunoblot compared with conditions incubated with apoE3 or apoE4 alone (p < 0.01). Aß1_40 also increased apoE immunoreactive levels but was significant only for the apoE4 isoform (p < 0.05). Control peptide Aß125 did not increase immunoreactive apoE levels significantly (p > 0.05).
Because the apoE-immunoreactive level s measured were complementary to those obtained by the classic binding and internalization study, it was reasonable to assume that Aß-immunoreactive levels may be interpreted in a similar fashion, i.e., that the immunoreactive Aß levels represent the binding and internalization (or uptake) of Aß by the hippocampal neurons. Immunoblots for Aß indicated that significantly higher levels of Aß1_41~were detectable in hippocampal neurons in the presence of apoE4-liposomes in comparison with apoE3-liposomes ( Fig. 4C; p < 0.01) . The antibodies used were not able to detect the Aß25_35 peptide.
DISCUSSION
The central findings of this study indicate that Aß peptides increase effectively the binding and internalization of apoE-liposomes to hippocampal neurons. The increase in binding was greater for the apoE4 isoform compared with the apoE3 isoform for each of the Aß peptides tested. These results are consistent with several lines of evidence linking apoE and Aß. First, apoE4 obtained from purified delipidated plasma (as used here before recombination with liposomes) has been shown to bind more avidly to Aß than apoE3 (Strittmatter et al., 1993) . More recent studies have challenged this finding (LaDu et al., 1994 (LaDu et al., , 1995 Zhou et al., 1996; Yang et al., 1997) ; however, it should be noted that the interaction of apoE and Aß in the presence of lipids has not yet been thoroughly evaluated, which may be critical because apoE is thought to undergo a conformational change when associated with lipid (Lund-Katz et al., 1993; Weisgraber, 1994) . Second, brain tissue from AD patients homozygous for the apoE 4 allele display significantly more Aß plaques than their 3 counterparts, perhaps reflective of a direct pathogenetic role for apoE in amyloid deposition (Rebeck et al., 1993; Schmechel et al., 1993; Beffert and Poirier, 1996) . At the present time, it is difficult to conclude precisely what this increase in apoE binding represents, and furthermore, how this may relate directly to the pathology of AD. The exact roles of both apoE and Aß in the brain are yet to be defined; however, if the primary role of apoE in the brain is to aid in neuronal plasticity (Poirier, 1994) , an increase in binding may be a response to increased neuronal damage/stress brought about by sublethal doses of Aß.
An alternate possibility is that apoE may serve multiple roles in the CNS, one of which may be to clear Binding (A and B) , internalization (C and D), and degradation (E and F) of 1251-apoE3-liposomes (A, C, and E) and 125l-apoE4-liposomes (B, D, and F) after 4-h incubation at 37°Cto primary rat hippocampal neurons in the presence of 1 jiM Aß 25~35peptide. The bound and internalized fractions were determined from the fractions that were sensitive or resistant to release by treatment with 25 mM sodium suramin. Degradation was determined from the trichioroacetic acid-nonprecipitable supernatant from the incubation media.
several lines of evidence. First, CSF Aß1_42 levels have been found to be lowered in AD compared with controls, perhaps due to increased clearance (Motter et al., 1995; Ida et al., 1996) . Second, microglial cells have been shown to internalize aggregates of Aß peptides through a scavenger receptor, whose ligands include acetylated and oxidized LDL (Paresce et al., 1996) . Finally, recent work has shown that the secreted form of APP can be internalized and degraded through LRP, one of the central apoE receptors in the brain (Kounnas et al., 1995) . Based on these observations, we hypothesize that Aß peptides interact directly with apoE lipoproteins, forming a complex that is bound and internalized into neuronal cells through apoE receptors. Together, these results further establish a functional relationship between apoE and Aß, which strengthens their combined role in the pathogenesis of AD.
The most common amyloidogenic fragments of AD neuritic plaques include Aß142 and Aß1.40 (Selkoe, 1994) . We have found that Aß142, Aß140, and Aß2535 are all effective at significantly increasing apoE3-and apoE4-liposome binding to hippocampal neurons. Each of these fragments is obtained from the lipophilic domain of the APP molecule (Selkoe, 1994) . This is consistent with studies showing that 5% of Aß added to plasma is bound to HDL, LDL, and VLDL particles (Biere et al., FIG. 4 . Relative immunoblot levels of apoE3 (A), apoE4 (B), and Aß 140 (C) obtained from neuronal cell homogenates after incubation with the indicated combinations of apoE and Aß at 1 jig/ ml each for 24 h at 37°C. For A and B, the insets demonstrate one representative immunoreactive band for each condition. In C, the inset demonstrates duplicate bands for Aß140 in the presence of apoE3-and apoE4-liposomes. Quantified signals were normalized for background (0%) and the first signal of each figure (100%) and each represents the mean of triplicate values from two separate cultures. The apoE-immunoreactive band was obtained at -~37kDa and the Aß band at -~4kDa.°p< 0.05; **p < 0.01, compared with the first column on each plot. 1996). A growing body of evidence now implicates cholesterol and lipids in Aß regulation in the CNS (Hartmann et al., 1994; Bodovitz and Klein, 1996; Kim and Suh, 1996; Koudinova et al., 1996) . In other control binding experiments, we demonstrate that Aß peptides including the lipophobic Aß125 fragment, scrambled Aß2535, and the reversed sequence Aß40_1 had no effect on apoE-liposome binding. Together, these results indicate that the Aß peptide has a lipophilic sequence-specific region that interacts with apoE-liposomes to increase apoE binding to hippocampal neurons.
One of the proposed functional roles for apoE in the brain is to aid in the process of neuronal plasticity by mediating the cellular uptake of lipoprotein particles through receptors of the LDL receptor family (Poirier, 1994) . We have demonstrated that both plasma human apoE3 and apoE4 isoforms bind comparably with rat primary hippocampal neurons in a specific and saturable process. These data are consistent with the comparable LDL receptor binding of apoE3-and apoE4-lipoprotein complexes to several other cell types (Weisgraber et al., 1982; Cassel et al., 1984) . With regard to neuronal cells, previous work by Ignatius et al. (1987) demonstrated that apoE-containing lipid particles and lipoproteins were internalized by neuntes and growth cones of pheochromocytoma cells. They implied that much of the internalization occurred through LDL receptors located in the growth cones and cell body of these cells. More recently, Bellosta et al. (1995) have demonstrated that uptake of ß-VLDL occurred to a similar extent in both apoE3-and apoE4-expressing murine neuroblastoma cells. Their data show that the LRP is primarily responsible for the uptake of lipid particles into ganglionic neuronal cells. We have further shown that the degradation of apoE3-liposome complexes is greater than that of apoE4-liposome complexes to hippocampal neurons. Differences in apoE isoform-specific binding, internalization, and degradation through neuronal LRP and/or LDL receptors may be responsible for the differential neunte outgrowth and development reported in several studies (Bellosta et al., 1995; Narita et al., 1997) . To date, a full characterization of all apoE receptors including the LDL receptor, LRP, VLDL receptor, and apoER2 on rat neuronal cells has not been performed. Combined, these findings confirm that apoE-liposome complexes are bound, internalized, and degraded through LDL receptors and/or LRP and that this interaction may be an important functional role for apoE in the brain.
To summarize, we have shown that Aß peptides increase significantly the binding of apoE-liposomes to hippocampal neurons, with apoE4 binding increased to a greater extent than apoE3. The lipophilic fragments of Aß were found to be responsible for mediating the increase in binding. The different binding properties of apoE4 versus apoE3 to hippocampal neurons in the presence of Aß may provide mechanistic understanding of the genetic association of apoE to AD. cheurs et l'Aide à la Recherche (FCAR) and from the Alzheimer Society ofMontreal. We thank Satyabrata Kar and Melanie Reuben for helpful comments.
